Tonghua Golden-Horse Pharmaceutical (SHE:000766) obtained a drug registration certificate for anveracrine succinate tablets, according to a Shenzhen bourse filing on Friday.
The drug is used for the treatment of symptoms of mild-to-moderate Alzheimer's disease.